thiazoles has been researched along with Cardiovascular Stroke in 75 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (6.67) | 18.7374 |
| 1990's | 8 (10.67) | 18.2507 |
| 2000's | 23 (30.67) | 29.6817 |
| 2010's | 35 (46.67) | 24.3611 |
| 2020's | 4 (5.33) | 2.80 |
| Authors | Studies |
|---|---|
| Albendín Iglesias, H; Arregui Montoya, F; Bailén Lorenzo, JL; Caro Martínez, C; Cerezo Manchado, JJ; Elvira Ruiz, G; Flores Blanco, PJ; García Alberola, A; Lova Navarro, A; Manzano-Fernández, S; Pascual Figal, DA | 1 |
| Lei, Q; Li, G; Li, H; Lv, Z; Wang, Y; Yan, Z; Yi, T | 1 |
| Su, G; Su, X; You, H | 1 |
| Goya, M; Hirao, K; Kawabata, M; Maeda, S; Sasano, T; Takahashi, Y; Yagishita, A | 1 |
| Clegg, A; Gale, CP; Hall, M; Kunadian, V; Rockwood, K; Searle, SD; Todd, O; Wilkinson, C; Wu, J | 1 |
| Antman, EM; Giugliano, RP; Hamershock, RA; Lanz, HJ; Mercuri, MF; Murphy, SA; Roy, D; Ruff, CT; Senior, R; Steffel, J | 1 |
| Choi, H; Dalal, D; Dubreuil, M; Felson, D; Neogi, T; Peloquin, C; Zhang, Y | 1 |
| Antman, EM; Braunwald, E; Giugliano, RP; Mercuri, MF; Miller, R; Morrow, D; Ruff, CT; Truitt, K; Weitz, JI; Yin, OQP | 1 |
| Fernández-Jiménez, R; Galán-Arriola, C; García-Álvarez, A; García-Prieto, J; García-Ruiz, JM; Ibanez, B; Lobo-Gonzalez, M; Piñero, A; Pizarro, G; Rossello, X; Sánchez-González, J; Sanz-Rosa, D; Vilchez, JP | 1 |
| Antman, EM; Botero, R; Braunwald, E; Corbalán, R; Garcia-Castillo, A; Giugliano, RP; Grip, LT; Hamershock, RA; Horna, M; López-Sendon, J; Nicolau, JC; Ruff, CT; Sotomora, G | 1 |
| Antman, EM; Giugliano, RP; Ruff, CT; Zelniker, TA | 1 |
| Gottsäter, A | 1 |
| Duncker, DJ; Gorsse-Bakker, C; Krabbendam-Peters, I; Sneep, S; Uitterdijk, A; van Beusekom, HM; van der Giessen, WJ; van Duin, RW | 1 |
| Larsen, TB; Lip, GY; Rasmussen, LH; Skjøth, F | 1 |
| Ke, T; Kong, D; Li, C; Li, L; Liu, Y; Wu, Y; Yao, X; Zhang, J | 1 |
| Antman, EM; Betcher, J; Braunwald, E; Cange, AL; Crompton, AE; Curt, V; Deenadayalu, N; Giugliano, RP; Grip, L; Mercuri, M; Murphy, SA; Ruff, CT | 1 |
| Amin, A; Bruno, A; Lin, J; Lingohr-Smith, M; Trocio, J | 1 |
| Akashi, H; Castillero, E; George, I; Homma, S; Ji, R; Kennel, PJ; Schulze, PC; Zizola, C | 1 |
| Myers, RB; Yoshioka, J | 1 |
| Chen, J; Chen, M; Dai, K; Huang, L; Wang, X; Zhou, W | 1 |
| Crawford, B; Morimoto, T; Ueda, S; Wada, K | 1 |
| Bodi, V; Bonanad, C; Chorro, FJ; de Dios, E; Forteza, MJ; Hervas, A; Miñana, G; Nuñez, J; Perez-Sole, N; Ruiz-Sauri, A | 1 |
| Chefu, SG; Demchenko, EA; Dmitriev, YV; Dracheva, AV; Galagudza, IM; Karpov, AA; Minasian, SM; Vasina, LV | 1 |
| Antman, EM; Braunwald, E; Geller, BJ; Giugliano, RP; Hanyok, JJ; Jin, J; Mercuri, M; Murphy, SA; Ruff, CT | 1 |
| Jiang, T; Li, Y; Liu, Q; Pan, K; Zhang, M; Zhou, X | 1 |
| Antman, EM; Awasty, VR; Braunwald, E; Eisen, A; Giugliano, RP; Gogia, HS; Henderson, DA; Mercuri, MF; Nordio, F; Ruff, CT; Rutman, H | 1 |
| Ahn, JH; Hwang, JY; Hwang, SJ; Jeong, YH; Jung, MH; Kim, JH; Koh, JS; Kwak, CH; Lee, YS; Park, JR; Park, Y; Seo, HG | 1 |
| Antman, EM; Braunwald, E; Corbalán, R; Dalby, A; Dorobantu, M; Eisen, A; Giugliano, RP; Lanz, H; Mercuri, M; Nordio, F; Ruff, CT; Rutman, H; Wiviott, SD | 1 |
| Chen, JH; Chou, TH; Chung, TW; Lo, HY; Wang, SS | 1 |
| Hosoi, Y; Murata, Y; Shiga, S; Uehara, Y | 1 |
| Guo, L; Hong, Y; Li, S; Wang, P; Zhong, X | 1 |
| Diness, JG; Hundahl, LA; Jespersen, T; Sattler, SM; Skibsbye, L; Tfelt-Hansen, J | 1 |
| Allen, JR; Biddlecome, G; Biswas, K; Bürli, RW; Chang, C; Dao, JH; Frohn, MJ; Hungate, RW; Peterkin, TA; Rogers, N; Tagari, P; Tegley, CM; Veith, H; Viswanadhan, VN; Yoder, SC | 1 |
| Ebel, D; Goletz, C; Grueber, Y; Huhn, R; Preckel, B; Schlack, W; Weber, NC | 1 |
| Becker, D; Beres, BJ; Fülöp, G; Kerecsen, G; Kiss, RG; Merkely, B; Preda, I; Spaulding, C; Szabó, G; Tóth-Zsamboki, E; Vargova, K | 1 |
| Antman, EM; Bocanegra, T; Braunwald, E; Crugnale, SE; Giugliano, RP; Hanyok, J; McCabe, CH; Mercuri, M; Patel, I; Ruff, CT; Salazar, D; Shi, M | 1 |
| D'Agostino, RB; Eng, SM; Faich, G; Kane, JM; Reynolds, RF; Ruskin, J; Strom, BL | 1 |
| Cheong, S; Jang, JK; Lee, C; Lee, JY; Shin, DH; Yoo, SY | 1 |
| Gao, W; Li, J; Lu, J; Morales, A; Xing, J | 1 |
| Ke, YN; Li, AL; Li, JH; Li, XL; Shi, ZX; Wang, Y; Yang, P | 1 |
| Böhm, M; Braun-Dullaeus, RC; de Waha, S; Desch, S; Ebelt, H; Eitel, I; Empen, K; Figulla, HR; Fuernau, G; Hambrecht, R; Hausleiter, J; Hennersdorf, M; Kurowski, V; Lauer, B; Maier, SK; Minden, HH; Möllmann, H; Neumann, FJ; Olbrich, HG; Rochor, K; Schneider, S; Schuler, G; Schwarz, B; Strasser, RH; Thiele, H; Werdan, K; Zeymer, U | 1 |
| Chen, H; Chen, HQ; Hu, XY; Jiang, Z; Liu, XB; Wang, JA; Wang, YP; Xiang, MX; Xu, YC; Zhu, MF | 1 |
| Kloner, RA; Reffelmann, T | 1 |
| Egashira, K; Hayashidani, S; Ikeuchi, M; Ishibashi, M; Kubota, T; Shiomi, T; Suematsu, N; Takeshita, A; Tsutsui, H; Wen, J | 1 |
| Bidouard, JP; Duval, N; Herbert, JM; Janiak, P; Kapui, Z; O'Connor, SE | 1 |
| Adamson, PB; Foreman, RD; Schwartz, PJ; Shibano, T; Vanoli, E | 1 |
| Görtz, A; Lander, T; Reblin, T; Seidel, D; Stein, D | 1 |
| Chou, TF; Lee, TM | 1 |
| Mocanu, MM; Yellon, DM | 1 |
| Thiemermann, C | 1 |
| Ballerio, R; Carboni, S; Cirillo, R; Ferrandi, C; Gaillard, P; Giachetti, C; Gotteland, JP; Vitte, PA | 1 |
| Eells, JT; Kersten, JR; Ludwig, LM; Pagel, PS; Tanaka, K; Warltier, DC; Weihrauch, D | 1 |
| Lauver, DA; Lockwood, SF; Lucchesi, BR | 1 |
| Hsiao, FY; Huang, WF; Shih, YT; Tsai, YW; Wen, YW | 1 |
| Baljinnyam, E; Fujino, T; Fukuzawa, J; Hasebe, N; Kikuchi, K; Matsusaka, T; Morihira, M; Sumitomo, K; Ushikubi, F | 1 |
| Hamlin, RL; Kijtawornrat, A; Lolly, JL; Roche, BM; Shemanski, D; Wessale, JL; Zhao, L | 1 |
| Glogar, D; Mayr, H; Mohl, W; Sochor, H; Weber, H | 1 |
| Klein, HH; Lindert-Heimberg, S; Maisch, B; Nebendahl, K; Pich, S | 1 |
| Araki, S; Hashimoto, H; Ishii, M; Nagashima, S; Nakashima, M; Uematsu, T; Umemura, K | 1 |
| Sternon, J | 1 |
| Adachi, Y; Akima, M; Fukazawa, M; Kato, T; Suzuki, Y; Tamura, K | 1 |
| Becker, LC; Bluemke, DA; Kim, RJ; Lima, JA; Rochitte, CE; Wu, KC; Zerhouni, EA | 1 |
| Auchampach, JA; Cavero, I; Gross, GJ; Pieper, GM | 1 |
| Jick, SS | 1 |
| Bao, W; Boyce, R; Bril, A; Buckingham, RE; Chen, J; Gu, JL; Hart, TK; Jiang, W; Lysko, PG; Narayanan, PK; Ohlstein, EH; Yue Tl, TL; Zimmerman, DM | 1 |
| Hawkey, CJ | 1 |
| Chatterjee, PK; Cuzzocrea, S; Hattori, Y; McDonald, MC; Mota-Filipe, H; Pisano, B; Thiemermann, C; Wayman, NS | 1 |
| Opie, LH; Sinclair-Smith, BC | 1 |
| Araki, S; Fukuchi, M; Hashimoto, H; Matsuzaki, T; Nagashima, S; Nakashima, M; Uematsu, T | 1 |
| Fantone, JC; Grum, CM; Hahn, RA; Ho, PP; Lucchesi, BR; Schork, MA; Towner, RD; Ventura, A; Werns, SW | 1 |
| Lucchesi, BR; Lynch, JJ; Montgomery, DG | 1 |
| Kondrat'ev, VS; Strukov, AI | 1 |
| Brunaud, M; Laborit, H; Vallée, E | 1 |
6 review(s) available for thiazoles and Cardiovascular Stroke
| Article | Year |
|---|---|
The efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and coronary artery disease: A meta-analysis of randomized trials.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Case-Control Studies; Clinical Trials, Phase III as Topic; Coronary Artery Disease; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Mortality; Myocardial Infarction; Pyridines; Randomized Controlled Trials as Topic; Safety; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2019 |
Comparative efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation: A network meta-analysis with the adjustment for the possible bias from open label studies.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Azetidines; Benzylamines; Dabigatran; Hemorrhage; Humans; Myocardial Infarction; Odds Ratio; Oligosaccharides; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiazoles; Thromboembolism; Treatment Outcome; Vitamin K | 2015 |
Comparative Efficacy of Clinical Events Prevention of Five Anticoagulants in Patients With Atrial Fibrillation (A Network Meta-Analysis).
Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Hemorrhage; Humans; Mortality; Myocardial Infarction; Network Meta-Analysis; Odds Ratio; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2017 |
[Post myocardial infarction management].
Topics: Aftercare; Anticholesteremic Agents; Antioxidants; Atorvastatin; Chromans; Clopidogrel; Diet, Fat-Restricted; Heptanoic Acids; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Pyrroles; Risk Factors; Thiazoles; Thiazolidinediones; Ticlopidine; Troglitazone | 1997 |
Cyclooxygenase inhibition: between the devil and the deep blue sea.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Gastroscopy; Humans; Isoenzymes; Kidney; Lactones; Meloxicam; Membrane Proteins; Myocardial Infarction; Prostaglandin-Endoperoxide Synthases; Proton Pump Inhibitors; Pyrazoles; Randomized Controlled Trials as Topic; Stomach Ulcer; Sulfonamides; Sulfones; Thiazines; Thiazoles | 2002 |
[Fluorescent microscopy in pathologico-anatomic practice].
Topics: Aldehydes; Aluminum; Calcium; Enzymes; Fats; Glycogen; Glycosaminoglycans; Histocytochemistry; Hydrogen-Ion Concentration; Ketones; Methods; Microscopy, Fluorescence; Mitochondria; Myocardial Infarction; Nucleic Acids; Staining and Labeling; Thiazoles | 1966 |
10 trial(s) available for thiazoles and Cardiovascular Stroke
| Article | Year |
|---|---|
Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Blood Coagulation; Double-Blind Method; Drug Administration Schedule; Factor Xa Inhibitors; Female; Follow-Up Studies; Frailty; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Pyridines; Thiazoles; Treatment Outcome; Warfarin | 2020 |
First experience with edoxaban and atrial fibrillation ablation - Insights from the ENGAGE AF-TIMI 48 trial.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Catheter Ablation; Double-Blind Method; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Pyridines; Thiazoles; Thrombolytic Therapy; Warfarin | 2017 |
Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial.
Topics: Aged; Dose-Response Relationship, Drug; Embolism; Factor Xa; Factor Xa Inhibitors; Female; Half-Life; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Pyridines; Risk Factors; Stroke; Thiazoles; Treatment Outcome | 2018 |
Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation: The ENGAGE AF-TIMI 48 Trial.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Double-Blind Method; Embolism; Factor Xa Inhibitors; Female; Hospitalization; Humans; Intracranial Hemorrhages; Latin America; Male; Myocardial Infarction; Pyridines; Stroke; Thiazoles; Warfarin | 2018 |
Transition of patients from blinded study drug to open-label anticoagulation: the ENGAGE AF-TIMI 48 trial.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Double-Blind Method; Drug Substitution; Factor Xa; Female; Humans; Male; Middle Aged; Myocardial Infarction; Pyridines; Thiazoles; Treatment Outcome; Warfarin | 2014 |
Systemic, noncerebral, arterial embolism in 21,105 patients with atrial fibrillation randomized to edoxaban or warfarin: results from the Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction
Topics: Aged; Anticoagulants; Atrial Fibrillation; Blood Coagulation; Double-Blind Method; Embolism; Factor Xa; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Middle Aged; Myocardial Infarction; Pyridines; Retrospective Studies; Thiazoles; Thrombolytic Therapy; Treatment Outcome; Warfarin | 2015 |
Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardi
Topics: Aged; Anticoagulants; Atrial Fibrillation; Blood Coagulation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Approval; Factor Xa; Factor Xa Inhibitors; Female; Humans; Male; Myocardial Infarction; Pyridines; Stroke; Thiazoles; Thrombolytic Therapy; United States; United States Food and Drug Administration; Warfarin | 2016 |
Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infar
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Pyridines; Retrospective Studies; Stroke; Thiazoles; Thrombolytic Therapy; Treatment Outcome; Warfarin | 2010 |
Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC).
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cause of Death; Cross-Sectional Studies; Death, Sudden, Cardiac; Diabetic Ketoacidosis; Female; Hospitalization; Humans; Incidence; Kaplan-Meier Estimate; Long QT Syndrome; Male; Middle Aged; Myocardial Infarction; Olanzapine; Piperazines; Product Surveillance, Postmarketing; Prospective Studies; Risk; Schizophrenia; Suicide; Thiazoles | 2011 |
Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.
Topics: Coronary Artery Bypass; Humans; Intra-Aortic Balloon Pumping; Myocardial Infarction; Prognosis; Prospective Studies; Research Design; Shock, Cardiogenic; Thiazoles | 2012 |
59 other study(ies) available for thiazoles and Cardiovascular Stroke
| Article | Year |
|---|---|
Effect of concomitant antiplatelet therapy in patients with nonvalvular atrial fibrillation initiating non-vitamin K antagonists.
Topics: Aged; Aged, 80 and over; Antithrombins; Aspirin; Atrial Fibrillation; Dabigatran; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Mortality; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Purinergic P2Y Receptor Antagonists; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Thiazoles | 2019 |
Ubiquitin C-terminal hydrolase L1 (UCHL1) regulates post-myocardial infarction cardiac fibrosis through glucose-regulated protein of 78 kDa (GRP78).
Topics: Animals; Disease Models, Animal; Endoplasmic Reticulum Chaperone BiP; Fibrosis; Heat-Shock Proteins; Mice; Myocardial Infarction; Myofibroblasts; Signal Transduction; Sulfonamides; Thiazoles; Transforming Growth Factor beta1; Ubiquitin Thiolesterase; Up-Regulation | 2020 |
Novel thiazole-pyrazolone hybrids as potent ACE inhibitors and their cardioprotective effect on isoproterenol-induced myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Apoptosis Regulatory Proteins; Cytokines; Disease Models, Animal; Drug Design; Inflammation Mediators; Isoproterenol; Male; Mitochondria, Heart; Myocardial Infarction; Myocytes, Cardiac; Oxidative Stress; Pyrazolones; Rats, Sprague-Dawley; Thiazoles | 2020 |
A Survey of Direct Oral Anticoagulant Cessation in General Surgery and Outcomes in Patients with Nonvalvular Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Blood Loss, Surgical; Carotid Artery Diseases; Cerebral Infarction; Dabigatran; Digestive System Surgical Procedures; Elective Surgical Procedures; Embolism; Endoscopy; Factor Xa Inhibitors; Female; Humans; Male; Myocardial Infarction; Orthopedic Procedures; Perioperative Care; Postoperative Complications; Postoperative Hemorrhage; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Thiazoles; Thromboembolism; Urologic Surgical Procedures; Vascular Surgical Procedures | 2020 |
Meloxicam and risk of myocardial infarction: a population-based nested case-control study.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Chi-Square Distribution; Cohort Studies; Cyclooxygenase 2 Inhibitors; Diclofenac; Female; Humans; Male; Meloxicam; Middle Aged; Myocardial Infarction; Odds Ratio; Risk Factors; Thiazines; Thiazoles | 2017 |
Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Animals; Disease Models, Animal; Magnetic Resonance Imaging, Cine; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Random Allocation; Swine; Thiazoles; Ventricular Function, Left; Ventricular Remodeling | 2018 |
[NOAC in combination with platelet antiaggregation in both patients with coronary and peripheral arterial disease].
Topics: Acute Coronary Syndrome; Anticoagulants; Antithrombins; Cardiovascular Diseases; Coronary Artery Disease; Dabigatran; Drug Therapy, Combination; Factor Xa Inhibitors; Humans; Myocardial Infarction; Myocardial Ischemia; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Sweden; Thiazoles | 2018 |
Serial measurement of hFABP and high-sensitivity troponin I post-PCI in STEMI: how fast and accurate can myocardial infarct size and no-reflow be predicted?
Topics: Animals; Benzothiazoles; Biomarkers; Coronary Circulation; Disease Models, Animal; Fatty Acid-Binding Proteins; Female; Hemodynamics; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Necrosis; No-Reflow Phenomenon; Predictive Value of Tests; Risk Factors; Staining and Labeling; Swine; Tetrazolium Salts; Thiazoles; Time Factors; Troponin I; Up-Regulation | 2013 |
Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. An indirect comparison analysis.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Female; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Myocardial Infarction; Precision Medicine; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Survival Analysis; Thiazoles; Thiophenes; Treatment Outcome | 2014 |
Netrin-1 ameliorates myocardial infarction-induced myocardial injury: mechanisms of action in rats and diabetic mice.
Topics: Analysis of Variance; Animals; Blotting, Western; DNA Primers; Genetic Vectors; Humans; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Myocardial Infarction; Nerve Growth Factors; Netrin-1; Nitric Oxide; Peptide Fragments; Phosphorylation; Rats; Rats, Sprague-Dawley; Retroviridae; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Transcription Factors; Transduction, Genetic; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2014 |
Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US.
Topics: Anticoagulants; Atrial Fibrillation; Cost-Benefit Analysis; Costs and Cost Analysis; Dabigatran; Health Expenditures; Hemorrhage; Humans; Models, Econometric; Myocardial Infarction; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; United States; Venous Thromboembolism; Warfarin | 2015 |
Activation of PPARδ signaling improves skeletal muscle oxidative metabolism and endurance function in an animal model of ischemic left ventricular dysfunction.
Topics: Adenosine Triphosphate; Animals; Cell Line; Disease Models, Animal; Energy Metabolism; Exercise Tolerance; Fatty Acids; Heart Failure; Mice, Inbred C57BL; Muscle Strength; Muscle, Skeletal; Myocardial Infarction; Oxidation-Reduction; Physical Endurance; PPAR gamma; Signal Transduction; Thiazoles; Time Factors; Transcription, Genetic; Ventricular Dysfunction, Left; Ventricular Function, Left | 2015 |
Regulating PPARδ signaling as a potential therapeutic strategy for skeletal muscle disorders in heart failure.
Topics: Animals; Energy Metabolism; Muscle, Skeletal; Myocardial Infarction; Physical Endurance; PPAR gamma; Thiazoles; Ventricular Dysfunction, Left; Ventricular Function, Left | 2015 |
The AMPK Agonist PT1 and mTOR Inhibitor 3HOI-BA-01 Protect Cardiomyocytes After Ischemia Through Induction of Autophagy.
Topics: AMP-Activated Protein Kinases; Animals; Animals, Newborn; Apoptosis; Autophagy; Benzodioxoles; Cell Hypoxia; Cells, Cultured; Cytoprotection; Disease Models, Animal; Glucose; Indoles; Male; meta-Aminobenzoates; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxygen; Protein Kinase Inhibitors; Signal Transduction; Thiazoles; TOR Serine-Threonine Kinases | 2016 |
Intracoronary Infusion of Thioflavin-S to Study Microvascular Obstruction in a Model of Myocardial Infarction.
Topics: Animals; Benzothiazoles; Coronary Angiography; Coronary Circulation; Coronary Occlusion; Coronary Vessels; Disease Models, Animal; Fluorescent Dyes; Infusions, Intra-Arterial; Microcirculation; Microvessels; Myocardial Infarction; Myocardial Reperfusion Injury; Photography; Sus scrofa; Swine; Thiazoles; Ultraviolet Rays | 2015 |
[CARDIOPROTFETIVE EFECTS OF NECROSTATIN-7 IN THE RAT MODEL OF PERMANENT CORONARY OCCLUSION].
Topics: Animals; Apoptosis; Autophagy; Cicatrix; Coronary Vessels; Disease Models, Animal; Heart Ventricles; Male; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Rats, Wistar; Thiazoles; Ventricular Remodeling | 2015 |
Growth differentiation factor 15 may protect the myocardium from no‑reflow by inhibiting the inflammatory‑like response that predominantly involves neutrophil infiltration.
Topics: Animals; Benzothiazoles; Cardiotonic Agents; Enzyme-Linked Immunosorbent Assay; Growth Differentiation Factor 15; Inflammation; Intercellular Adhesion Molecule-1; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Neutrophil Infiltration; No-Reflow Phenomenon; Peroxidase; Rats, Wistar; RNA, Messenger; Thiazoles; Time Factors | 2016 |
Effects of Peroxisome Proliferator-Activated Receptor-δ Agonist on Cardiac Healing after Myocardial Infarction.
Topics: Animals; Bone Marrow Cells; Cell Differentiation; Cell Movement; Chemokine CXCL12; Echocardiography; Fibrosis; Heart; Heart Ventricles; Infusions, Parenteral; Male; Matrix Metalloproteinase 9; Mesenchymal Stem Cells; Myocardial Infarction; Myocardium; Myofibroblasts; Platelet-Derived Growth Factor; PPAR delta; Rats; Rats, Sprague-Dawley; Signal Transduction; Thiazoles; Transforming Growth Factor beta2; Ventricular Remodeling | 2016 |
Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF-TIMI 48 Trial.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Cardiotonic Agents; Death, Sudden, Cardiac; Digitalis Glycosides; Factor Xa Inhibitors; Female; Heart Failure; Heart Rate; Humans; Hypertrophy, Left Ventricular; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Out-of-Hospital Cardiac Arrest; Proportional Hazards Models; Protective Factors; Pyridines; Risk Factors; Stroke Volume; Thiazoles | 2016 |
Promoting Cardiomyogenesis of hBMSC with a Forming Self-Assembly hBMSC Microtissues/HA-GRGD/SF-PCL Cardiac Patch Is Mediated by the Synergistic Functions of HA-GRGD.
Topics: Actins; Biocompatible Materials; Bone Marrow Cells; Caproates; Cell Differentiation; Cell Proliferation; Fibroins; Humans; Hyaluronic Acid; Lactones; Mesenchymal Stem Cells; Myocardial Infarction; Myocytes, Cardiac; Silk; Tetrazolium Salts; Thiazoles; Tissue Culture Techniques; Tissue Engineering; Tissue Scaffolds | 2017 |
NSAIDs diclofenac, indomethacin, and meloxicam highly upregulate expression of ICAM-1 and COX-2 induced by X-irradiation in human endothelial cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Contraindications; Cyclooxygenase 2; Diclofenac; E-Selectin; Heart; Human Umbilical Vein Endothelial Cells; Humans; Indomethacin; Intercellular Adhesion Molecule-1; Meloxicam; Myocardial Infarction; Myocardium; NF-kappa B; Nitriles; Risk Factors; Sulfones; Thiazines; Thiazoles; Up-Regulation; Vascular Cell Adhesion Molecule-1 | 2016 |
Pharmacological blockade of small conductance Ca
Topics: Animals; Arrhythmias, Cardiac; Male; Myocardial Infarction; Potassium Channel Blockers; Pyridines; Rats; Rats, Sprague-Dawley; Small-Conductance Calcium-Activated Potassium Channels; Thiazoles | 2017 |
Discovery of novel hydroxy-thiazoles as HIF-alpha prolyl hydroxylase inhibitors: SAR, synthesis, and modeling evaluation.
Topics: Chemistry, Pharmaceutical; Diabetes Mellitus; Drug Design; Drug Evaluation, Preclinical; Erythrocytes; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Inhibitory Concentration 50; Models, Chemical; Models, Molecular; Myocardial Infarction; Peripheral Vascular Diseases; Stroke; Structure-Activity Relationship; Thiazoles | 2008 |
Blockade of anaesthetic-induced preconditioning in the hyperglycaemic myocardium: the regulation of different mitogen-activated protein kinases.
Topics: Anesthetics; Anesthetics, Inhalation; Animals; Blood Glucose; Blood Pressure; Blotting, Western; Desflurane; Electrocardiography; Gene Expression Regulation, Enzymologic; Heart Rate; Hyperglycemia; Ischemic Preconditioning, Myocardial; Isoflurane; Male; Mitogen-Activated Protein Kinases; Myocardial Infarction; Myocardium; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Wistar; Tetrazolium Salts; Thiazoles | 2008 |
Very late drug-eluting stent thrombosis after nonsteroidal anti-inflammatory drug treatment despite dual antiplatelet therapy.
Topics: Adult; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Thrombosis; Cyclooxygenase Inhibitors; Diabetic Angiopathies; Diclofenac; Drug Interactions; Drug-Eluting Stents; Endothelium, Vascular; Humans; Intervertebral Disc Displacement; Male; Meloxicam; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Thiazines; Thiazoles; Ticlopidine; Time Factors | 2009 |
Clinical outcomes of brief versus prolonged unfractionated heparin infusion after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in the drug-eluting stent era: real-world, single-centre experience.
Topics: Aged; Anticoagulants; Coronary Angiography; Drug-Eluting Stents; Female; Heparin; Hospital Mortality; Humans; Infusions, Intravenous; Intra-Aortic Balloon Pumping; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Thiazoles | 2011 |
Muscle cyclo-oxygenase-2 pathway contributes to the exaggerated muscle mechanoreflex in rats with congestive heart failure.
Topics: Animals; Blood Pressure; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Heart Failure; Heart Rate; Kidney; Male; Membrane Proteins; Muscle Contraction; Muscle, Skeletal; Myocardial Infarction; Piperazines; Pyrazoles; Rats; Rats, Sprague-Dawley; Reflex, Stretch; Sulfonamides; Sympathetic Nervous System; Thiazoles | 2012 |
The preventive effect of garlicin on a porcine model of myocardial infarction reperfusion no-reflow.
Topics: Allyl Compounds; Animals; Benzothiazoles; Cardiotonic Agents; Contrast Media; Disease Models, Animal; Disulfides; Hemodynamics; Male; Myocardial Infarction; Myocardial Reperfusion; No-Reflow Phenomenon; Swine; Swine, Miniature; Thiazoles; Ultrasonography | 2014 |
Angiopoietin-1 preconditioning enhances survival and functional recovery of mesenchymal stem cell transplantation.
Topics: Angiopoietin-1; Animals; Apoptosis; Cell Survival; Chromones; Culture Media; Echocardiography; Enzyme Inhibitors; In Situ Nick-End Labeling; Mesenchymal Stem Cell Transplantation; Morpholines; Myocardial Infarction; Phosphorylation; Rats; Rats, Sprague-Dawley; Tetrazolium Salts; Thiazoles; Transplantation Conditioning; Treatment Outcome | 2012 |
Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit.
Topics: Animals; Benzothiazoles; Coronary Circulation; Fluorescent Dyes; Hemorrhage; Male; Microcirculation; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Rabbits; Thiazoles | 2002 |
Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Topics: Administration, Oral; Animals; Aspartate Aminotransferases; Blood Glucose; Cytokines; Disease Models, Animal; Disease Progression; Drug Administration Schedule; Echocardiography; Gene Expression; Heart Failure; Heart Ventricles; Hemodynamics; Male; Matrix Metalloproteinase 9; Mice; Myocardial Infarction; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Observer Variation; Organ Size; Pioglitazone; Receptors, Cytoplasmic and Nuclear; Reproducibility of Results; RNA, Messenger; Survival Rate; Thiazoles; Thiazolidinediones; Transcription Factors; Ventricular Dysfunction, Left; Ventricular Remodeling | 2002 |
SSR69071, an elastase inhibitor, reduces myocardial infarct size following ischemia-reperfusion injury.
Topics: Animals; Cyclic S-Oxides; Dose-Response Relationship, Drug; Leukocyte Elastase; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Rabbits; Thiazoles | 2003 |
Combined sodium and calcium channel blockade in prevention of lethal arrhythmias.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Death, Sudden, Cardiac; Depression, Chemical; Dogs; Drug Synergism; Drug Therapy, Combination; Heart Rate; Isoproterenol; Myocardial Infarction; Physical Conditioning, Animal; Propranolol; Sodium Channel Blockers; Thiazoles; Ventricular Fibrillation | 2003 |
[Preventing infarct in the diabetic patient. Lowering blood glucose and HbA1c are not enough].
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Glucose Clamp Technique; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Resistance; Myocardial Infarction; Rosiglitazone; Thiazoles; Thiazolidinediones | 2003 |
Troglitazone administration limits infarct size by reduced phosphorylation of canine myocardial connexin43 proteins.
Topics: Animals; Blood Glucose; Blotting, Western; Cardiotonic Agents; Chromans; Connexin 43; Dogs; Dose-Response Relationship, Drug; Free Radical Scavengers; Hemodynamics; Insulin; Male; Microscopy, Confocal; Myocardial Infarction; Myocardium; Phosphorylation; Superoxides; Thiazoles; Thiazolidinediones; Troglitazone | 2003 |
p53 down-regulation: a new molecular mechanism involved in ischaemic preconditioning.
Topics: Androstadienes; Animals; Benzothiazoles; Blotting, Northern; Down-Regulation; Enzyme Inhibitors; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Nuclear Proteins; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Precipitin Tests; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-mdm2; Rats; Rats, Sprague-Dawley; Thiazoles; Toluene; Tumor Suppressor Protein p53; Wortmannin | 2003 |
Ligands of the peroxisome proliferator-activated receptor-gamma and heart failure.
Topics: Animals; Disease Models, Animal; Heart Failure; Humans; Ligands; Mice; Myocardial Infarction; Pioglitazone; PPAR gamma; Rats; Thiazoles; Thiazolidinediones | 2004 |
Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats.
Topics: Acetonitriles; Anesthesia; Animals; Apoptosis; Benzothiazoles; Blood Pressure; Blotting, Western; Coronary Disease; DNA Fragmentation; Enzyme Activation; Heart Rate; Hemodynamics; Immunohistochemistry; In Situ Nick-End Labeling; JNK Mitogen-Activated Protein Kinases; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Sprague-Dawley; Thiazoles | 2004 |
Preconditioning by isoflurane is mediated by reactive oxygen species generated from mitochondrial electron transport chain complex III.
Topics: Adenosine Triphosphate; Anesthetics, Inhalation; Animals; Coenzymes; Electron Transport; Enzyme Inhibitors; Hemodynamics; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Isoflurane; Male; Methacrylates; Mitochondria, Heart; Myocardial Infarction; NADH Dehydrogenase; Onium Compounds; Rabbits; Reactive Oxygen Species; Thiazoles; Ubiquinone; Ventricular Function, Left | 2004 |
Disodium Disuccinate Astaxanthin (Cardax) attenuates complement activation and reduces myocardial injury following ischemia/reperfusion.
Topics: Adjuvants, Immunologic; Animals; beta Carotene; C-Reactive Protein; Complement Activation; Complement Inactivator Proteins; Complement Membrane Attack Complex; Erythrocytes; Fluorescent Antibody Technique; Hemodynamics; Hemolysis; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Rabbits; Tetrazolium Salts; Thiazoles; Tissue Distribution; Troponin I; Xanthophylls | 2005 |
Cardiovascular events associated with long-term use of celecoxib, rofecoxib and meloxicam in Taiwan: an observational study.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Angina Pectoris; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2 Inhibitors; Databases, Factual; Female; Humans; Insurance, Pharmaceutical Services; Ischemic Attack, Transient; Lactones; Male; Meloxicam; Middle Aged; Myocardial Infarction; National Health Programs; Proportional Hazards Models; Pyrazoles; Risk Assessment; Stroke; Sulfonamides; Sulfones; Taiwan; Thiazines; Thiazoles; Time Factors | 2006 |
Oral pretreatment with ebselen enhances heat shock protein 72 expression and reduces myocardial infarct size.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Administration, Oral; Animals; Antioxidants; Azoles; Benzhydryl Compounds; Cells, Cultured; Deoxyguanosine; Gene Expression; Glutathione; HSP72 Heat-Shock Proteins; Hydrogen Peroxide; In Vitro Techniques; Isoindoles; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Organoselenium Compounds; Oxidative Stress; Pyrrolidinones; Rabbits; Rats; Rats, Sprague-Dawley; Selenium; Tetrazolium Salts; Thiazoles | 2006 |
Chronic xanthine oxidase inhibition following myocardial infarction in rabbits: effects of early versus delayed treatment.
Topics: Allopurinol; Animals; Body Weight; Echocardiography; Enzyme Inhibitors; Febuxostat; Heart Failure; Male; Myocardial Infarction; Myocardium; Organ Size; Rabbits; Thiazoles; Time Factors; Xanthine Oxidase | 2008 |
[Experimental model for determination of an "in vivo" area at risk accounting for the quantity and distribution of collateral flow (author's transl)].
Topics: Animals; Arrhythmias, Cardiac; Autoradiography; Benzothiazoles; Collateral Circulation; Coronary Circulation; Disease Models, Animal; Dogs; Fluorescent Dyes; Microspheres; Myocardial Infarction; Risk; Serum Albumin; Thiazoles | 1982 |
Effects of R56865, an Na(+)- and Ca(2+)-overload inhibitor, on myocardial injury in ischemic, reperfused porcine hearts.
Topics: Animals; Benzothiazoles; Blood Pressure; Calcium; Calcium Channel Blockers; Coronary Circulation; Female; Heart Rate; Injections, Intravenous; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Oxygen Consumption; Piperidines; Sodium; Sodium Channel Blockers; Swine; Thiazoles; Ventricular Fibrillation | 1995 |
Comparison of electrophysiologic and hemodynamic effects of SD-3212, a new antiarrhythmic drug, and flecainide in a canine myocardial infarction model.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Cardiac Output; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electrophysiology; Flecainide; Heart Conduction System; Hemodynamics; Myocardial Infarction; Thiazoles | 1994 |
CP-060S, a novel cardioprotective drug, limits myocardial infarct size in anesthetized dogs.
Topics: Animals; Calcium Channel Blockers; Cardiovascular Agents; Dogs; Hemodynamics; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Necrosis; Thiazoles; Thiazolidines | 1998 |
Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion.
Topics: Animals; Benzothiazoles; Coloring Agents; Contrast Media; Coronary Circulation; Dogs; Echocardiography; Fluorescent Dyes; Magnetic Resonance Imaging; Microcirculation; Microspheres; Myocardial Infarction; Myocardial Reperfusion Injury; Tetrazolium Salts; Thiazoles; Time Factors | 1998 |
Effect of the platelet-activating factor antagonist RP 59227 (Tulopafant) on myocardial ischemia/reperfusion injury and neutrophil function.
Topics: Animals; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Female; Free Radicals; Incidence; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Neutrophils; Peroxidase; Platelet Activating Factor; Pyridines; Reperfusion Injury; Thiazoles; Ventricular Fibrillation | 1998 |
The risk of gastrointestinal bleed, myocardial infarction, and newly diagnosed hypertension in users of meloxicam, diclofenac, naproxen, and piroxicam.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Databases, Factual; Diclofenac; Gastrointestinal Hemorrhage; Humans; Hypertension; Isoenzymes; Meloxicam; Membrane Proteins; Myocardial Infarction; Naproxen; Piroxicam; Prostaglandin-Endoperoxide Synthases; Risk Assessment; Thiazines; Thiazoles; United Kingdom | 2000 |
In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
Topics: Animals; CD18 Antigens; Cell Adhesion Molecules; Chemokine CCL2; Diabetes Complications; Hypoglycemic Agents; Macrophage-1 Antigen; Macrophages; Male; Monocytes; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Neutrophil Infiltration; Neutrophils; Rats; Rats, Inbred Lew; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors | 2001 |
[Infarct prevention for diabetics. To lower blood sugar is not enough].
Topics: Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibrinolytic Agents; Humans; Hypoglycemic Agents; Insulin Resistance; Myocardial Infarction; Risk Factors; Rosiglitazone; Thiazoles; Thiazolidinediones; Vasodilator Agents | 2001 |
[Type 2 diabetes. How can the infarction risk be reduced?].
Topics: Acarbose; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Metformin; Myocardial Infarction; Pioglitazone; Risk Factors; Rosiglitazone; Thiazoles; Thiazolidinediones; Time Factors; Vasodilator Agents | 2002 |
Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
Topics: Adult; Animals; Cardiotonic Agents; Cell Adhesion Molecules; Cell Line; Cells, Cultured; Chemokine CCL2; Clofibrate; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Ligands; Male; Membrane Proteins; Myocardial Infarction; Myocardial Reperfusion Injury; Pioglitazone; Prostaglandin D2; Prostaglandins A; Protein Isoforms; Pyrimidines; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors | 2002 |
Effect of diabetic ketosis on enzyme release from isolated perfused rat hearts with experimental myocardial infarction.
Topics: Adenosine Triphosphate; Animals; Blood Glucose; Diabetic Ketoacidosis; Fatty Acids, Nonesterified; Heart; Hydroxybutyrates; Hypolipidemic Agents; Insulin; L-Lactate Dehydrogenase; Myocardial Infarction; Myocardium; Perfusion; Rats; Thiazoles | 1978 |
Antiarrhythmic and electrophysiological effects of SD-3212, a novel Na+ and Ca++ channel blocker, in anaesthetized dogs with myocardial infarction in comparison with its stereoisomer (SD-3211) and bepridil.
Topics: Animals; Anti-Arrhythmia Agents; Bepridil; Calcium Channel Blockers; Dogs; Electrophysiology; Female; Heart; Heart Conduction System; Male; Myocardial Infarction; Sodium Channels; Stereoisomerism; Thiazoles | 1992 |
Xanthine oxidase inhibition does not limit canine infarct size.
Topics: Animals; Dogs; Free Radicals; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Oxypurinol; Thiazoles; Time Factors; Xanthine Oxidase | 1991 |
The effects of calcium entry blockade on the vulnerability of infarcted canine myocardium toward ventricular fibrillation.
Topics: Animals; Benzothiazoles; Bepridil; Calcium Channel Blockers; Diltiazem; Dogs; Electrocardiography; Electrophysiology; Heart; Heart Rate; Male; Myocardial Infarction; Pyrrolidines; Thiazoles; Ventricular Fibrillation | 1986 |
[The action of 2-amino-4-(isothioureyl methyl)-thiazol dihydrochloride (Agr 307) on the catecholamines of the central nervous system in the rat. Possible inhibition of dopamine beta-hydroxylase].
Topics: Animals; Brain; Catecholamines; Dopamine; Hypertension; Male; Mixed Function Oxygenases; Monoamine Oxidase Inhibitors; Myocardial Infarction; Nialamide; Norepinephrine; Rats; Reserpine; Thiazoles | 1971 |